Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury

被引:134
作者
de Boer, Ynto S. [1 ,2 ]
Kosinski, Andrzej S. [3 ]
Urban, Thomas J. [4 ]
Zhao, Zhen [5 ]
Long, Nanye [4 ]
Chalasani, Naga [6 ]
Kleiner, David E. [7 ]
Hoofnagle, Jay H. [8 ]
机构
[1] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
[2] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
[3] Duke Clin Res Inst, Durham, NC USA
[4] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[5] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA
[6] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[7] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
[8] NIDDK, Liver Dis Res Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Database Analysis; Toxicity; Hepatotoxicity; Immune Response; Immunoglobulin; CAUSALITY ASSESSMENT; NETWORK DILIN; OUTCOMES; FAILURE; HEPATOTOXICITY; MINOCYCLINE; METHYLDOPA; DIAGNOSIS; TYPE-1; COHORT;
D O I
10.1016/j.cgh.2016.05.043
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Drug-induced liver injury (DILI) has features similar to those of other liver diseases including autoimmune hepatitis (AIH). We aimed to characterize the clinical and autoimmune features of liver injury caused by nitrofurantoin, minocycline, methyldopa, or hydralazine. METHODS: We analyzed data from 88 cases of DILI attributed to nitrofurantoin, minocycline, methyldopa, or hydralazine included in the Drug-Induced Liver Injury Network prospective study from 2004 through 2014. Sera were collected from patients at baseline and follow-up examination and tested for levels of immunoglobulin G (IgG), antibodies to nuclear antigen (ANA), smooth muscle (SMA), and soluble liver antigen (SLA). An autoimmune score was derived on the basis of increases in levels of IgG, ANA, SMA, and SLA (assigned values of 0, 1+, or 2+). AIH- associated HLA-DRB1*03:01 and HLA-DRB1*04:01 allele frequencies were compared with those of the general population (controls). RESULTS: Of the 88 cases, 80 were women (91%), 74% had hepatocellular injury, and 25% had severe injury. At the onset of DILI, 39% of cases had increased levels of IgG, 72% had increased levels of ANA, 60% had increased levels of SMA, and none had increases in SLA. A phenotype of autoimmunity (autoimmune score >= 2) was observed in 82% of cases attributed to nitrofurantoin and 73% of cases attributed to minocycline (73%) but only 55% of cases attributed to methyldopa and 43% of cases attributed to hydralazine (P = .16 for nitrofurantoin and minocycline vs methyldopa and hydralazine). We observed a decrease in numbers of serum samples positive for ANA (P = .01) or SMA (P <.001) and in autoimmune scores (P <.001) between DILI onset and follow-up. Similar percentages of patients with DILI had HLA-DRB1*03: 01 (15%) and HLA-DRB1*04: 01 (9%) as controls (12% and 9%, respectively). CONCLUSIONS: In analysis of data from the DILIN prospective study, we found that most cases of DILI attributed to nitrofurantoin or minocycline and about half of cases that were due to methyldopa and hydralazine have a phenotype of autoimmunity similar to AIH. These features decrease with recovery of the injury and are not associated with the typical HLA alleles found in patients with idiopathic AIH.
引用
收藏
页码:103 / +
页数:12
相关论文
共 33 条
  • [1] International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis
    Alvarez, E
    Berg, PA
    Bianchi, FB
    Bianchi, L
    Burroughs, AK
    Cancado, EL
    Chapman, RW
    Cooksley, WGE
    Czaja, AJ
    Desmet, VJ
    Donaldson, RT
    Eddleston, ALWF
    Fainboim, L
    Heathcote, J
    Homberg, JC
    Hoofnagle, JH
    Kakumu, S
    Krawitt, EL
    Mackay, IR
    MacSween, RNM
    Maddrey, WC
    Manns, MP
    McFarlane, IG
    zum Büschenfelde, KHM
    Mieli-Vergani, G
    Nakanuma, Y
    Nishioka, M
    Penner, E
    Porta, G
    Portmann, BC
    Reed, WD
    Rodes, J
    Schalm, SW
    Scheuer, PJ
    Schrumpf, E
    Seki, T
    Toda, G
    Tsuji, T
    Tygstrup, N
    Vergani, D
    Zeniya, M
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (05) : 929 - 938
  • [2] The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study
    Berna, William
    Ma, Yun
    Smith, Heather M.
    Portmann, Bernard
    Wendon, Julia
    Vergani, Diego
    [J]. JOURNAL OF HEPATOLOGY, 2007, 47 (05) : 664 - 670
  • [3] Drug-Induced Autoimmune Hepatitis: Clinical Characteristics and Prognosis
    Bjoernsson, Einar
    Talwalkar, Jayant
    Treeprasertsuk, Sombat
    Kamath, Patrick S.
    Takahashi, Naoki
    Sanderson, Schuyler
    Neuhauser, Matthias
    Lindor, Keith
    [J]. HEPATOLOGY, 2010, 51 (06) : 2040 - 2048
  • [4] Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
    Bjornsson, Einar S.
    Bergmann, Ottar M.
    Bjornsson, Helgi K.
    Kvaran, Runar B.
    Olafsson, Sigurdur
    [J]. GASTROENTEROLOGY, 2013, 144 (07) : 1419 - U168
  • [5] Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease
    Castiella, Agustin
    Zapata, Eva
    Lucena, M. Isabel
    Andrade, Raul J.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (04) : 160 - 168
  • [6] Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
    Chalasani, Naga
    Bonkovsky, Herbert L.
    Fontana, Robert
    Lee, William
    Stolz, Andrew
    Talwalkar, Jayant
    Reddy, K. Rajendar
    Watkins, Paul B.
    Navarro, Victor
    Barnhart, Huiman
    Gu, Jiezhun
    [J]. GASTROENTEROLOGY, 2015, 148 (07) : 1340 - +
  • [7] Drug-Induced Autoimmune-Like Hepatitis
    Czaja, Albert J.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (04) : 958 - 976
  • [8] Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
    de Boer, Ynto S.
    van Gerven, Nicole M. F.
    Zwiers, Antonie
    Verwer, Bart J.
    van Hoek, Bart
    van Erpecum, Karel J.
    Beuers, Ulrich
    van Buuren, Henk R.
    Drenth, Joost P. H.
    den Ouden, Jannie W.
    Verdonk, Robert C.
    Koek, Ger H.
    Brouwer, Johannes T.
    Guichelaar, Maureen M. J.
    Vrolijk, Jan M.
    Kraal, Georg
    Mulder, Chris J. J.
    van Nieuwkerk, Carin M. J.
    Fischer, Janett
    Berg, Thomas
    Stickel, Felix
    Sarrazin, Christoph
    Schramm, Christoph
    Lohse, Ansgar W.
    Weiler-Normann, Christina
    Lerch, Markus M.
    Nauck, Matthias
    Voelzke, Henry
    Homuth, Georg
    Bloemena, Elisabeth
    Verspaget, Hein W.
    Kumar, Vinod
    Zhernakova, Alexandra
    Wijmenga, Cisca
    Franke, Lude
    Bouma, Gerd
    [J]. GASTROENTEROLOGY, 2014, 147 (02) : 443 - +
  • [9] SUSCEPTIBILITY TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS - HUMAN-LEUKOCYTE ANTIGENS-DR4 AND ANTIGEN-A1-B8-DR3 ARE INDEPENDENT RISK-FACTORS
    DONALDSON, PT
    DOHERTY, DG
    HAYLLAR, KM
    MCFARLANE, IG
    JOHNSON, PJ
    WILLIAMS, R
    [J]. HEPATOLOGY, 1991, 13 (04) : 701 - 706
  • [10] Drug-Induced Liver Injury Network (DILIN) Prospective Study Rationale, Design and Conduct
    Fontana, Robert J.
    Watkins, Paul B.
    Bonkovsky, Herbert L.
    Chalasani, Naga
    Davern, Timothy
    Serrano, Jose
    Rochon, James
    [J]. DRUG SAFETY, 2009, 32 (01) : 55 - 68